#CancerTrials
From CAR-T approaches to bispecific antibodies, scientists are learning how to guide immune cells directly to cancer. Each clinical trial moves the field a little closer to better, more precise treatments.

#CancerTrials #PrecisionMedicine #CancerScience #TCSC
March 14, 2026 at 8:16 AM
A Birmingham clinical trial is testing ways to manage cancer with fewer side effects, putting quality of life front and centre. #CancerTrials #TCSC #BBC
www.bbc.com/news/article...
Birmingham trial aims to manage cancer with fewer side effects
A trial starts to see if it can be treated while the worst side effects are drastically reduced.
www.bbc.com
February 18, 2026 at 9:00 AM
I-PREDICT trial: precision drug combos improve cancer care
World’s first global clinical trial proves individualised drug combinations based on a patient’s tumour DNA can be safe and more effective than standard approaches. www.news-medical.net/news/2026010... #PrecisionMedicine #CancerTrials #TCSC
Individualized drug combinations improve cancer treatment outcomes
Researchers at University of California San Diego School of Medicine have led the first clinical trial in the world to show that cancer drug treatments can be safely and effectively personalized based...
www.news-medical.net
January 10, 2026 at 11:52 AM
Explore clinical trials for multiple myeloma/plasma cell myeloma. Filter by age, location & trial type—some at NCI-Designated Cancer Centers with additional support. #MultipleMyeloma #CancerTrials #TCSC

www.cancer.gov/research/par...
FacebookFollow on XInstagramYoutubeLinkedin
www.cancer.gov
August 8, 2025 at 7:36 AM
Medical experts have hailed as a "game changer" trials of a drug that could reduce the recurrence of bladder cancer! #TCSC #bladdercancer #cancerdrugs #cancertrials #cancercare #bbc

www.bbc.co.uk/news/article...
Experts hail bladder cancer treatment 'breakthrough'
Overall survival rates were 25% higher among patients who received durvalumab, trial shows.
www.bbc.co.uk
January 16, 2025 at 8:05 AM
We are delighted to share that recruitment for our Phase II VADER trial for patients with advanced bowel cancer is now complete, at nine centres across Australia.

➡️ Learn more: https://ow.ly/jfI450Y0ZtS

AGITG and GI Cancer Institute
#CancerTrials #BowelCancer #ColorectalCancer
January 23, 2026 at 2:00 AM
ONJCRI is thrilled to announce that Prof Eliza Hawkes and Prof Hui Gan have received MRFF Clinical Trials Activity funding to lead new and impactful clinical trials for blood and brain cancer patients.

➡️ https://ow.ly/mEgi50XZUuX

#ClinicalTrials #CancerTrials #Glioblastoma #Lymphoma #MRFF
January 20, 2026 at 2:15 AM
ONCOLOGY NEWS: Can AI improve the accuracy of identifying patients eligible for oncology clinical trials? Explore new research: t.ly/Jo5N3 #AI #ArtificalIntelligence #OncologyResearch #OncologyClinicalTrials #CancerTrials #CancerResearch #TrialParticipantSelection
February 24, 2026 at 5:18 PM
#Telemedicine offers comparable recruitment and enrollment onto #clinicaltrials as in-person visits, and may help improve equitable access, suggests research published in @cancertherapyadv.bsky.social.

https://bit.ly/4lLBDoc

#CancerTrials
Telemedicine Is a Feasible Means of Enrolling Patients in Clinical Trials - Oncology Nurse Advisor
In this retrospective study, researchers explored the impact of telemedicine on recruitment and enrollment in a large phase 1 clinical trial program.
bit.ly
March 28, 2026 at 11:47 PM
#COVID pioneer #BioNTech:
The fall of #Germany 's #pandemic hero

@biontech.bsky.social , once celebrated for its #COVID19 #vaccines, is grappling with falling demand, restructuring and the departure of its founders.

#cancertrials #biotech
www.dw.com/en/germanys-...
COVID pioneer BioNTech: The fall of Germany's pandemic hero
BioNTech, once celebrated for its COVID-19 vaccines, is grappling with falling demand, restructuring and the departure of its founders. Can its ambitious cancer trials turn it from a one-hit wonder in...
www.dw.com
May 7, 2026 at 1:35 PM
Health care professionals say: We’re not geared to care for vulnerable populations.
At #AACR25, the PAACT project shared key changes to boost Black/African American access to cancer clinical trials.
#HealthEquity #CancerTrials
buff.ly/Vozl9ze
May 1, 2025 at 2:06 PM
New JHEOR study finds that crossover rates above 42.7% in oncology trials often dilute treatment efficacy, leading to nonsignificant overall survival results, emphasizing the need for mitigation strategies in trial design. jheor.org/article/163160 #HEOR #HTA #CancerTrials
July 7, 2026 at 4:51 PM
OneMedNet stock rises after partnership with Inka Health for cancer trials
Investing.com -- OneMedNet Corporation (NASDAQ:ONMD) stock gained 6% premarket after announcing a partnership with Inka Health Corp., a subsidiary of Onco-Innovations Limited (CBOE CA:ONCO), to develop external control arms for cancer therapy trials. The collaboration will leverage OneMedNet’s patient data platform alongside Inka Health’s SynoGraph platform, which combines machine learning with causal inference methods. The initial focus will be on building and validating an external control arm for the Keynote-189 trial of pembrolizumab in non-small cell lung cancer. External control arms serve as alternatives to traditional clinical trial control groups, potentially reducing development timelines and costs for pharmaceutical companies. The project aims to replicate clinical trial results using real-world data while adhering to regulatory standards from the FDA, European Medicines Agency, and National Institute for Health and Care Excellence. "We selected Inka Health for this initiative because their methodological approach aligns perfectly with our vision for high-quality evidence generation," said Aaron Green, President and CEO of OneMedNet. Paul Arora, Co-Founder of Inka Health, stated the project aims to "set a new bar for how external control arms can be built and trusted" using real-world patient data. The companies plan to submit a scientific abstract on their findings to ISPOR Europe 2025. OneMedNet currently operates a network of over 1,750 healthcare sites through its iRWD platform, providing medical imaging and electronic health records data. According to market research cited by the companies, the Real-World Evidence market is projected to exceed $4.6 billion globally by 2030. This article was generated with the support of AI and reviewed by an editor. For more information see our T&C. Don't miss out on the next big opportunity! Stay ahead of the curve with ProPicks AI – 6 model portfolios fueled by AI stock picks with a stellar performance this year... In 2024 alone, ProPicks AI identified 2 stocks that surged over 150%, 4 additional stocks that leaped over 30%, and 3 more that climbed over 25%. That's an impressive track record. With portfolios tailored for Dow stocks, S&P stocks, Tech Stocks, and Mid Cap stocks, you can explore various wealth-building strategies. So if ONMD is on your watchlist, it could be very wise to know whether or not it made the ProPicks AI lists.
www.investing.com
July 31, 2025 at 1:44 PM
We are pleased to share information about a study on recurrent cervical cancer.
The trial is now open at UCD Cancer Trials and is being conducted at the Mater Misericordiae University Hospital (MMUH) in Dublin.

👉 Read more about the trial here: www.ucd.ie/cancertrials...
MK-2870: Exploring a New Therapy for Women with Recurrent Cervical Cancer - Cancer Trials Cluster
www.ucd.ie
October 3, 2025 at 9:52 AM
Join us for an evening where science meets real stories. 🎙️

📖 The Living Stories Behind Cancer Research
🗓️ Oct 7 | 5:30–7:00pm
📍 Museum of Literature Ireland (MoLI), Stephen’s Green

🪑 Limited spots.
👉 Register now: www.ucd.ie/cancertrials...
The Living Stories Behind Cancer Research - Cancer Trials Cluster
www.ucd.ie
September 25, 2025 at 2:56 PM
🩸 September is Blood Cancer Awareness Month — a time to spotlight innovation in haematology.

👉 Learn more about Dr Smyth: www.ucd.ie/cancertrials...

🔬 Explore current haematology trials at the Cancer Trials Cluster: www.ucd.ie/cancertrials...
LinkedIn
This link will take you to a page that’s not on LinkedIn
lnkd.in
September 9, 2025 at 3:33 PM
Join us Oct 7 for The Living Stories Behind Cancer Research at MoLI!
Inspired by the Human Library, come and “borrow” a patient, nurse, researcher & more for real talks on cancer research.
Registration and more information: www.ucd.ie/cancertrials...
The Living Stories Behind Cancer Research - Cancer Trials Cluster
www.ucd.ie
September 3, 2025 at 9:45 AM
🔬 Science Meets Lived Experience
Jim discovered PPI via a hospital poster in 2020. Now he’s shaping cancer research & national health data projects with lived insight.
📢 Read at Science Meets Lived Experience: www.ucd.ie/cancertrials...
Science Meets Lived Experience: Patients Shaping Health Research in Ireland - Cancer Trials Cluster
www.ucd.ie
June 23, 2025 at 4:16 PM
As we shared recently, the Phase III OASIS-4 trial results are now published.
A proud moment for our teams, collaborators, and especially the patients who made this possible.
📖 Read more about the results and their implications at our website:
www.ucd.ie/cancertrials...
Thank you to all involved!
Phase III OASIS-4 Trial Results Published in the New England Journal of Medicine - Cancer Trials Cluster
www.ucd.ie
June 16, 2025 at 11:31 AM
Last Saturday, 7th June, we took part in the University College Dublin Festival 2025.
At the UCD Clinical Research Centre stand, adults, families, teenagers and even toddlers joined us to explore the world of clinical research through.
www.ucd.ie/cancertrials...
UCD Festival 2025 - Cancer Trials Cluster
www.ucd.ie
June 10, 2025 at 2:07 PM
📢 We’re proud to announce that Prof. Grainne O'Kane has been appointed Director of the UCD Cancer Cluster, succeeding Prof. Michaela Higgins.

www.ucd.ie/cancertrials...
Gráinne O'Kane Appointed New Director of UCD Cancer Trial Cluster - Cancer Trials Cluster
www.ucd.ie
June 6, 2025 at 9:40 AM
Cut From The Same Cloth: Where art, science & community meet.

Led by UCD Prof. Amanda McCann, this project explores the common threads between lived experience and scientific inquiry, amplifying minority voices in health science.
www.ucd.ie/cancertrials...
Cut from the same Cloth - Cancer Trials Cluster
www.ucd.ie
May 8, 2025 at 8:31 AM
Be part of cutting-edge cancer research happening at UCD Cancer Trial Cluster.
Our upcoming trials offer hope through innovation — with access to the latest therapies for gynaecological, breast, lung, and other cancers.

www.ucd.ie/cancertrials...
Upcoming Clinical Trials - Cancer Trials Cluster
www.ucd.ie
April 30, 2025 at 6:29 AM